Clinical Application of a Dermal Substitute based on glycerol preserved Allograft: GLYADERM® A multicentre, prospective, controlled, randomized, comparative trial of Glyaderm® and split thickness skin graft versus split thickness skin graft alone in full thickness skin defects - Multicentre evaluation Glyaderm®

Euro Tissue Bank0 个研究点目标入组 2 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

Trial is onging in other countries

•All clearly full thickness burns or skin defects (TBSA Full Thickness Burn < 30%) as clinically evaluated by two plastic surgeons and/or specialist burn surgeons
•Possibility to follow the complete treatment schedule until final graft take and subsequently wound healing and finally participation in the follow-up schedule
•Informed consent has been obtained

•All partial thickness burns that can heal by conservative treatment
•Patients younger than 18 years of age
•TBSA > 30 %
•Study wound smaller than 100 cm² or greater than 800cm2.
•No follow-up till wound closure or withdrawal before start of follow-up
•Patient has any condition(s) that seriously compromises the patient*s ability to complete this study
•Patient has participated in another study utilizing an investigational drug within the previous 30 days
•Patient has one or more medical condition(s), diabetes, including renal, hepatic, hematologic, neurologic, or immune disease that in the opinion of the investigator would make the patient an inappropriate candidate for this study

发起方

Euro Tissue Bank